Ask AI
SACHI
SACHI: Phase III Trial of Savolitinib + Osimertinib vs Chemotherapy in EGFR-Mutant, MET-Amplified Advanced NSCLC After an EGFR TKI

Released: June 03, 2025

Expiration: December 02, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 03, 2025

Expiration: December 02, 2025